Copyright Reports & Markets. All rights reserved.

Global Brain Tumor Diagnosis And Therapeutics Market Professional Survey Report 2019

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Brain Tumor Diagnosis And Therapeutics Industry
  • 1.7 COVID-19 Impact: Brain Tumor Diagnosis And Therapeutics Market Trends

    • 2 Global Brain Tumor Diagnosis And Therapeutics Quarterly Market Size Analysis

    • 2.1 Brain Tumor Diagnosis And Therapeutics Business Impact Assessment - COVID-19
      • 2.1.1 Global Brain Tumor Diagnosis And Therapeutics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Brain Tumor Diagnosis And Therapeutics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Brain Tumor Diagnosis And Therapeutics Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Brain Tumor Diagnosis And Therapeutics Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Brain Tumor Diagnosis And Therapeutics Market
    • 3.4 Key Players Brain Tumor Diagnosis And Therapeutics Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Brain Tumor Diagnosis And Therapeutics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 MRI
      • 1.4.2 CT Scan
      • 1.4.3 Tissue Sampling
      • 1.4.4 PET-CT Scan
      • 1.4.5 Cerebral Arteriogram
      • 1.4.6 Lumbar Puncture
      • 1.4.7 Molecular Testing
      • 1.4.8 EEG
    • 4.2 By Type, Global Brain Tumor Diagnosis And Therapeutics Market Size, 2019-2021

    5 Impact of Covid-19 on Brain Tumor Diagnosis And Therapeutics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Surgery
      • 5.5.2 Radiation Therapy
      • 5.5.3 Chemotherapy
      • 5.5.4 Immunotherapy
      • 5.5.5 Targeted Therapy
    • 5.2 By Application, Global Brain Tumor Diagnosis And Therapeutics Market Size, 2019-2021
      • 5.2.1 By Application, Global Brain Tumor Diagnosis And Therapeutics Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 GE Healthcare
      • 7.1.1 GE Healthcare Business Overview
      • 7.1.2 GE Healthcare Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.1.3 GE Healthcare Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.1.4 GE Healthcare Response to COVID-19 and Related Developments
    • 7.2 Hitachi
      • 7.2.1 Hitachi Business Overview
      • 7.2.2 Hitachi Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.2.3 Hitachi Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.2.4 Hitachi Response to COVID-19 and Related Developments
    • 7.3 Philips Healthcare
      • 7.3.1 Philips Healthcare Business Overview
      • 7.3.2 Philips Healthcare Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.3.3 Philips Healthcare Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.3.4 Philips Healthcare Response to COVID-19 and Related Developments
    • 7.4 Siemens Healthineers
      • 7.4.1 Siemens Healthineers Business Overview
      • 7.4.2 Siemens Healthineers Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.4.3 Siemens Healthineers Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.4.4 Siemens Healthineers Response to COVID-19 and Related Developments
    • 7.5 Toshiba Corporation
      • 7.5.1 Toshiba Corporation Business Overview
      • 7.5.2 Toshiba Corporation Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.5.3 Toshiba Corporation Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.5.4 Toshiba Corporation Response to COVID-19 and Related Developments
    • 7.6 Fujifilm Corporation
      • 7.6.1 Fujifilm Corporation Business Overview
      • 7.6.2 Fujifilm Corporation Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.6.3 Fujifilm Corporation Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.6.4 Fujifilm Corporation Response to COVID-19 and Related Developments
    • 7.7 Shimadzu Corporation
      • 7.7.1 Shimadzu Corporation Business Overview
      • 7.7.2 Shimadzu Corporation Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.7.3 Shimadzu Corporation Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.7.4 Shimadzu Corporation Response to COVID-19 and Related Developments
    • 7.8 Carestream Health
      • 7.8.1 Carestream Health Business Overview
      • 7.8.2 Carestream Health Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.8.3 Carestream Health Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.8.4 Carestream Health Response to COVID-19 and Related Developments
    • 7.9 Merck & Co.
      • 7.9.1 Merck & Co. Business Overview
      • 7.9.2 Merck & Co. Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.9.3 Merck & Co. Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.9.4 Merck & Co. Response to COVID-19 and Related Developments
    • 7.10 Astra Zeneca
      • 7.10.1 Astra Zeneca Business Overview
      • 7.10.2 Astra Zeneca Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.10.3 Astra Zeneca Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.10.4 Astra Zeneca Response to COVID-19 and Related Developments
    • 7.11 Bristol Myer Squibb
      • 7.11.1 Bristol Myer Squibb Business Overview
      • 7.11.2 Bristol Myer Squibb Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.11.3 Bristol Myer Squibb Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.11.4 Bristol Myer Squibb Response to COVID-19 and Related Developments
    • 7.12 Novartis
      • 7.12.1 Novartis Business Overview
      • 7.12.2 Novartis Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.12.3 Novartis Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.12.4 Novartis Response to COVID-19 and Related Developments
    • 7.13 Roche Diagnostics
      • 7.13.1 Roche Diagnostics Business Overview
      • 7.13.2 Roche Diagnostics Brain Tumor Diagnosis And Therapeutics Quarterly Revenue, 2020
      • 7.13.3 Roche Diagnostics Brain Tumor Diagnosis And Therapeutics Product Introduction
      • 7.13.4 Roche Diagnostics Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Brain Tumor Diagnosis And Therapeutics, including the following market information:
      Global Brain Tumor Diagnosis And Therapeutics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Brain Tumor Diagnosis And Therapeutics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Brain Tumor Diagnosis And Therapeutics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Brain Tumor Diagnosis And Therapeutics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include GE Healthcare, Hitachi, Philips Healthcare, Siemens Healthineers, Toshiba Corporation, Fujifilm Corporation, Shimadzu Corporation, Carestream Health, Merck & Co., Astra Zeneca, Bristol Myer Squibb, Novartis, Roche Diagnostics, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      MRI
      CT Scan
      Tissue Sampling
      PET-CT Scan
      Cerebral Arteriogram
      Lumbar Puncture
      Molecular Testing
      EEG

      Based on the Application:
      Surgery
      Radiation Therapy
      Chemotherapy
      Immunotherapy
      Targeted Therapy

      Buy now